2020:
Development of a new class of diarylpentadienone analogues as anti-diabetic agents: Synthesis, in vitro biological and in vivo toxicity evaluations, and molecular docking analyses
2020:
Development of a new class of diarylpentadienone analogues as alpha-glucosidase inhibitor: Synthesis, in vitro biological and in vivo toxicity evaluations, and molecular docking analyses